Filing Details
- Accession Number:
- 0001127602-20-018935
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2020-06-04 21:45:45
- Reporting Period:
- 2020-05-12
- Accepted Time:
- 2020-06-04 21:45:45
- Original Submission Date:
- 2020-05-12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1682852 | Moderna Inc. | MRNA | () | 4/A |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1619929 | G Elizabeth Nabel | C/O Moderna, Inc. 200 Technology Square Cambridge MA 02139 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-05-12 | 30,000 | $66.00 | 14,344 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on March 11, 2020.